Psychedelics for Depression: Between Hopes and Uncertainties.
Focus (Am Psychiatr Publ) April 15, 2025 DOI: 10.1176/appi.focus.20250005 via PubMed Central
Summary
AI-generated from the abstractThe use of psychedelics to treat depression is surrounded by both optimism and unresolved questions. The text examines the gap between high expectations and the current evidence base, highlighting that while early results are promising, significant uncertainties remain about efficacy, safety, and mechanisms of action. It calls for cautious interpretation and further rigorous research before these substances can be considered a standard treatment.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key finding | Psychedelics show potential for treating depression but face substantial uncertainties that require more research before clinical adoption. |
Abstract
Psychedelics for Depression: Between Hopes and Uncertainties.